APA (7th ed.) Citation

He, B., Lin, R., Xu, N., Qin, L., Wang, Z., Wang, Q., . . . Liu, Q. (2025). Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: Results of a pivotal trial. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-025-06608-x

Chicago Style (17th ed.) Citation

He, Bailin, et al. "Efficacy and Safety of Third-generation CD19-CAR T Cells Incorporating CD28 and TLR2 Intracellular Domains for B-cell Malignancies with Central Nervous System Involvement: Results of a Pivotal Trial." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-025-06608-x.

MLA (9th ed.) Citation

He, Bailin, et al. "Efficacy and Safety of Third-generation CD19-CAR T Cells Incorporating CD28 and TLR2 Intracellular Domains for B-cell Malignancies with Central Nervous System Involvement: Results of a Pivotal Trial." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-025-06608-x.